ANAPTYSBIO, INC (ANAB)
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company’s products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b trial for celiac disease and eosinophilic esophagitis; ANB101, a BDCA2 modulator antibody which is in Phase 1a trial that specifically targets plasmacytoid dendritic cells and inhibits interferon secretion and modulates antigen presentation; dostarlimab, a PD-1 antagonist for various solid tumor indications; and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. It focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has collaborations agreement with GSK and Vanda. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
AnaptysBio, Inc.
- 1.5:1Forward splitApr 20, 20261 share → 1.5
- 1.5:1Forward splitApr 20, 20261 share → 1.5
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Revenue | $234.6M | $91.28M | $17.16M | $10.29M | $63.17M | $75M | $8M | $5M | $10M | $16.68M | $17.57M | $15.84M | $5.48M |
| YoY Growth | 157.0% | 432.0% | 66.8% | -83.7% | -15.8% | 837.5% | 60.0% | -50.0% | -40.1% | -5.0% | 10.9% | 188.9% | - |
| Cost of Revenue | $2.42M | $163.84M | $132.28M | $88.8M | $98.5M | $80.03M | $99.34M | $56.2M | $29.44M | $15.42M | $17.3M | $8.61M | $8.82M |
| Gross Profit | $232.18M | -$72.56M | -$115.13M | -$78.51M | -$35.32M | -$5.03M | -$91.34M | -$51.2M | -$19.44M | $1.26M | $267K | $7.22M | -$3.34M |
| Gross Margin | 99.0% | -79.5% | -671.0% | -763.2% | -55.9% | -6.7% | -1141.7% | -1023.9% | -194.4% | 7.6% | 1.5% | 45.6% | -60.9% |
| Research and Development | $135.97M | $163.84M | $139.62M | $88.8M | $98.5M | $80.03M | $99.34M | $56.3M | $30.94M | $22.62M | $17.3M | $8.61M | $8.82M |
| Selling, General, and Administrative | $50.74M | $42.39M | $41.95M | $36.64M | $21.49M | $18.85M | $16.09M | $15.53M | $9.34M | $4.29M | $3.59M | $2.35M | $1.95M |
| Other | -$2.42M | -$163.84M | -$132.28M | -$88.8M | -$98.5M | -$80.03M | -$99.34M | -$56.3M | -$30.94M | -$22.62M | -$17.3M | -$8.61M | $0 |
| Total Operating Expenses | $184.28M | $42.39M | $49.28M | $36.64M | $21.49M | $18.85M | $16.09M | $15.53M | $9.34M | $4.29M | $3.59M | $2.35M | $1.32M |
| Operating Income (EBIT) | $47.9M | -$114.95M | -$164.41M | -$115.15M | -$56.81M | -$23.88M | -$107.43M | -$66.72M | -$28.78M | -$3.02M | -$3.32M | $4.87M | -$5.29M |
| Operating Margin | 20.4% | -125.9% | -958.3% | -1119.4% | -89.9% | -31.8% | -1342.9% | -1334.4% | -287.8% | -18.1% | -18.9% | 30.7% | -96.4% |
| Interest Expense | $79.89M | $50.09M | $18.08M | $21.11M | $1.45M | $0 | $1.04M | $1.65M | $1.77M | $458K | $460K | $1.28M | $886K |
| Interest Income | $13.5M | $19.79M | $18.87M | $7.55M | $431K | $3.96M | $10.98M | $6.68M | $1.62M | $0 | $0 | $2K | $1K |
| Other Income (Expense) | -$60.96M | -$30.28M | $788K | -$13.55M | -$982K | $3.95M | $9.94M | $4.87M | -$1.29M | -$1.23M | -$1.94M | -$1.34M | -$258K |
| Income Before Tax (EBT) | -$13.07M | -$145.23M | -$163.62M | -$128.7M | -$57.8M | -$19.93M | -$97.49M | -$61.85M | -$30.07M | -$4.26M | -$5.27M | $3.53M | -$5.54M |
| Income Tax Expense | $164K | $3K | -$4K | $24K | $0 | $0 | -$152K | -$192K | $0 | $0 | $139K | $0 | $0 |
| Net Income | -$13.23M | -$145.23M | -$163.62M | -$128.72M | -$57.8M | -$19.93M | -$97.34M | -$61.66M | -$30.07M | -$4.26M | -$5.41M | $232K | -$5.54M |
| Net Income Margin | -5.6% | -159.1% | -953.7% | -1251.3% | -91.5% | -26.6% | -1216.7% | -1233.1% | -300.7% | -25.5% | -30.8% | 1.5% | -101.1% |
| Supplementary Data | |||||||||||||
| EPS | -0.46 | -5.12 | -6.08 | -4.57 | -2.11 | -0.73 | -3.60 | -2.50 | -1.52 | -0.23 | -0.38 | 0.24 | -2.28 |
| Diluted EPS | -0.46 | -5.12 | -6.08 | -4.57 | -2.11 | -0.73 | -3.60 | -2.50 | -1.52 | -0.23 | -0.36 | 0.24 | -2.23 |
| Weighted Average OS | 27.79M | 28.38M | 26.92M | 28.16M | 27.43M | 27.30M | 27.06M | 24.67M | 19.78M | 2.64M | 2.55M | 2.48M | 1.11M |
| EBITDA | $69.25M | -$92.74M | -$154.7M | -$105.26M | -$55.71M | -$19.37M | -$95.93M | -$59.88M | -$28.11M | -$3.57M | -$4.53M | $5.12M | -$4.08M |
| EBITDA Margin | 29.5% | -101.6% | -901.6% | -1023.2% | -88.2% | -25.8% | -1199.2% | -1197.6% | -281.1% | -21.4% | -25.8% | 32.3% | -74.4% |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $238.2M | $123.08M | $35.97M | $71.31M | $495.73M | $250.46M | $171.02M | $113.6M | $81.19M | $51.23M | $51.68M | $22.19M | $2.81M |
| Short-Term Investments | $73.44M | $262.29M | $354.94M | $369.93M | $52.37M | $143.2M | $203.21M | $313.49M | $167.22M | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $311.64M | $385.37M | $390.9M | $441.24M | $548.1M | $393.65M | $374.23M | $427.08M | $248.41M | $51.23M | $51.68M | $22.19M | $2.81M |
| Accounts Receivable | $33.85M | $40.77M | $6.85M | $1.42M | $876K | $0 | $0 | $174K | $1.6M | $5.34M | $1.23M | $1.46M | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $4.76M | $5.74M | $9.08M | $4.54M | $0 | $0 | $0 | $0 | $0 | $0 | $554K | $758K | $0 |
| Total Current Assets | $350.25M | $431.88M | $406.83M | $447.2M | $553.88M | $396.56M | $377.73M | $434.22M | $252.7M | $58.21M | $53.46M | $24.4M | $3.05M |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $13.89M | $16.23M | $18.27M | $19.99M | $21.84M | $2.13M | $1.62M | $1.45M | $665K | $471K | $551K | $579K | $750K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $35.47M | $27.03M | $142.94M | $67.1M | $17.55M | $54.3M | $73.13M | $75.9M | $60K | $60K | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $256K | $256K | $256K | $256K | $256K | $318K | $1.54M | $208K | $106K | $3.44M | $2.21M | $85K | $110K |
| Total Long-Term Assets | $14.14M | $51.96M | $45.55M | $163.18M | $89.19M | $19.99M | $57.46M | $74.78M | $76.67M | $3.97M | $2.82M | $664K | $860K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $364.39M | $483.83M | $452.39M | $610.38M | $643.07M | $416.55M | $435.2M | $509M | $329.36M | $62.18M | $56.28M | $25.07M | $3.91M |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $3.87M | $4M | $4.7M | $2.78M | $1.74M | $4.22M | $16.24M | $5.44M | $2.32M | $2.28M | $1.52M | $415K | $197K |
| Short-Term Debt | $0 | $1.93M | $0 | $0 | $0 | $0 | $1.38M | $7.57M | $6.88M | $0 | $0 | $0 | $818K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $139K | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $8.7M | $4.86M | $3.43M | $2.94M | $10.09M | $1.29M |
| Other Current Liabilities | $11.09M | $31.05M | $23.77M | $5.38M | $4.18M | $3.69M | $2.15M | $2.42M | $1.59M | $973K | $772K | $588K | $485K |
| Total Current Liabilities | $38.63M | $45.43M | $37.44M | $26.05M | $16.1M | $19.82M | $29.54M | $21.84M | $14.09M | $5.71M | $7.38M | $11.68M | $3.16M |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $12.03M | $353.43M | $0 | $0 | $0 | $0 | $0 | $625K | $7.55M | $13.81M | $4.9M | $4.79M | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $171K | $140K | $154K | $115K | $1.94M | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$171K | -$140K | -$154K | -$115K | $0 | $0 |
| Other Long-Term Liabilities | $276.53M | $0 | $310.81M | $304.41M | $251.09M | $0 | $0 | $171K | $140K | $3.4M | $1.66M | $569K | $607K |
| Total Long-Term Liabilities | $288.56M | $367.54M | $326.84M | $322.23M | $270.54M | $0 | $654K | $796K | $7.69M | $17.2M | $6.57M | $7.39M | $607K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $327.19M | $412.97M | $364.29M | $348.28M | $286.64M | $19.82M | $30.19M | $22.63M | $21.78M | $22.91M | $13.94M | $19.07M | $3.77M |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $77.52M | $77.52M | $36.83M | $34.67M |
| Common Stock | $28K | $30K | $27K | $29K | $28K | $27K | $27K | $27K | $24K | $3K | $3K | $17K | $17K |
| Retained Earnings | -$772.56M | -$759.33M | -$614.1M | -$450.48M | -$321.75M | -$263.96M | -$244.03M | -$146.69M | -$85.03M | -$54.92M | -$50.66M | -$45.26M | -$48.79M |
| Comprehensive Income & Other | -$24K | $305K | -$797K | -$5.25M | -$422K | -$4K | $338K | -$223K | -$426K | -$3.8M | -$3.58M | -$3.35M | -$3.11M |
| Other Stockholders' Equity | $809.74M | $830.16M | $702.17M | $712.55M | $678.15M | $660.66M | $649.01M | $633.03M | $392.59M | $94.19M | $93M | $51.23M | $48.92M |
| Total Equity | $37.21M | $70.87M | $88.1M | $262.1M | $356.43M | $396.73M | $405.01M | $486.37M | $307.58M | $39.27M | $42.34M | $5.99M | $145K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $364.39M | $483.83M | $452.39M | $610.38M | $643.07M | $416.55M | $435.2M | $509M | $329.36M | $62.18M | $56.28M | $25.07M | $3.91M |
| Supplementary Data | |||||||||||||
| Total Debt | $14.11M | $369.46M | $17.81M | $19.45M | $20.95M | $342K | $2.9M | $8.26M | $14.45M | $13.81M | $4.92M | $4.92M | $932K |
| Net Debt | -$224.08M | $246.38M | -$18.15M | -$51.86M | -$474.77M | -$250.11M | -$168.12M | -$105.34M | -$66.74M | -$37.42M | -$46.76M | -$17.27M | -$1.88M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Operating Activities | |||||||||||||
| Net Income | $49.61M | -$145.23M | -$163.62M | -$128.72M | -$57.8M | -$19.93M | -$97.34M | -$61.66M | -$30.07M | -$4.26M | -$5.41M | $3.53M | -$5.54M |
| Depreciation & Amortization | $2.42M | $2.4M | $2.38M | $2.33M | $2.09M | $559K | $514K | $315K | $183K | $233K | $274K | $308K | $580K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.23M | $1.38M | $757K | $1.28M | $62K | -$621K |
| Stock-Based Compensation | $36.07M | $34.05M | $33.2M | $27.36M | $15.35M | $11.5M | $12.41M | $9.96M | $4.38M | $1.16M | $604K | $160K | $151K |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | $6.92M | -$33.91M | -$5.43M | -$543K | -$876K | $0 | $174K | $1.43M | $1.23M | $1K | $229K | -$1.46M | $268K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$237.97M | -$5.34M | $343K | -$489K | $132K |
| Accounts Payable | -$87.33M | -$33.84M | $10.94M | $9.7M | -$4.74M | $0 | $0 | $7.08M | $2.22M | $1.25M | $1.95M | $482K | -$255K |
| Other Working Capital | -$313K | $1.43M | -$5.83M | -$2.32M | -$1.87M | -$6.77M | $16.68M | -$3.62M | $238.61M | -$2.94M | -$9.05M | $10.73M | -$1.39M |
| Total Working Capital Change | -$80.72M | -$66.33M | -$324K | $6.84M | -$7.49M | -$6.77M | $16.85M | $3.46M | $4.08M | -$7.03M | -$6.53M | $9.27M | -$1.25M |
| Other Non-Cash Items | $12.31M | $39.77M | $7.56M | $18.6M | $1.93M | $487K | -$1.96M | $646K | $619K | $105K | $110K | $1.27M | $886K |
| Net Cash from Operating | $19.7M | -$135.34M | -$120.8M | -$73.59M | -$45.92M | -$14.16M | -$69.52M | -$48.51M | -$19.44M | -$9.03M | -$9.67M | $14.6M | -$5.8M |
| Investing Activities | |||||||||||||
| Capital Expenditures | -$87K | -$358K | -$807K | -$358K | -$1.37M | -$569K | -$805K | -$1.06M | -$290K | -$50K | -$238K | -$145K | -$37K |
| Acquisitions | $0 | $0 | $0 | $394.49M | $0 | $0 | $0 | $347.54M | $290.9M | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$196.41M | -$380.38M | -$303.92M | -$802.5M | -$118.66M | -$194.93M | -$251.81M | -$347.54M | -$290.9M | $0 | $0 | $0 | $0 |
| Sales of Investments | $424.53M | $476.13M | $449.48M | $408.02M | $158.85M | $289.97M | $384.05M | $206.15M | $48.14M | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | -$394.49M | $15K | $0 | $0 | -$347.54M | -$290.9M | $0 | $0 | $5K | $0 |
| Net Cash from Investing | $228.03M | $95.4M | $144.75M | -$394.85M | $38.84M | $94.47M | $131.43M | -$142.45M | -$243.06M | -$50K | -$238K | -$140K | -$37K |
| Financing Activities | |||||||||||||
| Debt Repaid | $76.8M | -$34.77M | $11.73M | - | - | - | - | $6.88M | - | -$10M | - | -$5M | - |
| Common Stock Issuance | $14.26M | $100.84M | $2.47M | $11.83M | $2.55M | $496K | $3.01M | $227.48M | $292.54M | $31K | $160K | $0 | $4K |
| Common Stock Repurchases | -$68.63M | -$456K | -$50M | $0 | $0 | $0 | $0 | $0 | $0 | -$1K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$1.45M | -$8.1M | -$43K | $32.19M | $249.75M | $0 | $0 | $2.76M | -$84K | -$1.37M | -$1.45M | -$85K | $0 |
| Net Cash from Financing | -$132.61M | $127.05M | -$59.3M | $44.02M | $252.3M | -$879K | -$4.49M | $223.36M | $292.45M | $8.63M | $39.4M | $4.92M | $1.96M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $115.12M | $87.11M | -$35.34M | -$424.42M | $245.21M | $79.44M | $57.42M | $32.41M | $29.96M | -$452K | $29.5M | $19.38M | -$3.87M |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | $19.7M | -$135.34M | -$120.8M | -$73.59M | -$45.92M | -$14.16M | -$69.52M | -$48.51M | -$19.44M | -$9.03M | -$9.67M | $14.6M | -$5.8M |
| Capital Expenditure | -$87K | -$358K | -$807K | -$358K | -$1.37M | -$569K | -$805K | -$1.06M | -$290K | -$50K | -$238K | -$145K | -$37K |
| Free Cash Flow | $19.61M | -$135.69M | -$121.61M | -$73.95M | -$47.29M | -$14.73M | -$70.32M | -$49.57M | -$19.73M | -$9.08M | -$9.91M | $14.46M | -$5.83M |
| Cash at Beginning | $123.08M | $35.97M | $71.31M | $495.73M | $250.52M | $171.02M | $113.6M | $81.25M | $51.29M | $51.68M | $22.19M | $2.81M | $6.68M |
| Cash at End | $238.2M | $123.08M | $35.97M | $71.31M | $495.73M | $250.46M | $171.02M | $113.66M | $81.25M | $51.23M | $51.68M | $22.19M | $2.81M |